Hansson Henrik H

Show results for

Proteomics (3)
Unknown (1)

Organisms

Alphavirus (2)
Anemia (2)
Archaea (2)
Bacteria (2)
Betaherpesvirinae (2)
Borrelia (2)
Chlorella vulgaris (2)
Clostridium perfringens (2)
Dengue virus (2)
Eukaryota (2)
Hepatitis B virus (2)
Human alphaherpesvirus 1 (2)
Human betaherpesvirus 5 (2)
Influenza A virus (2)
Influenza C virus (2)
Japanese encephalitis virus group (2)
Kamptonema sp. (2)
Listeria monocytogenes (2)
Mammarenavirus (2)
Miscanthus x giganteus (2)
Mus musculus (2)
Mycobacterium tuberculosis (2)
Orthoflavivirus (2)
Panicum virgatum (2)
Pseudomonas aeruginosa (2)
Rattus (2)
Severe acute respiratory syndrome coronavirus 2 (2)
Staphylococcus aureus (2)
Streptococcus pneumoniae (2)
Homo sapiens (1)

Repository

pride (2)
PanoramaPublic (1)

Tissue

Cerebrospinal fluid (2)

Disease

Alzheimer's disease (1)
Parkinson's disease (1)

Technology Type

Mass Spectrometry (2)
Shotgun proteomics (2)

Publication Date

2019 (2)
2017 (1)

Release Date

2025 (1)

Lab affiliation

- Inst. of Neuroscience and Physiology, Dept. of Psychiatry and Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden - Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden - Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, UK (1)
Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden Department of Molecular Neuroscience, University College London Institute of Neurology, Queen Square, London, UK UK Dementia Research Institute at UCL, London, United Kingdom (1)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

Expanding the cerebrospinal fluid endopeptidome

Biomarkers of neurodegenerative disorders are needed to assist in diagnosis, to monitor disease progression and therapeutic interventions, and to provide insight into disease mechanisms. One route to identify such biomarkers is by proteomic and peptidomic analysis of cerebrospinal fluid (CSF). In t...

ORGANISM(S): Homo sapiens (Human)

2017-01-17 | PXD004863 | Pride

Endo-Lysosomal and Ubiquitin CSF Biomarker Discovery by solid-phase extraction and LC-MS/MS

Dysfunctional proteostasis is increasingly implicated in neurodegenerative diseases which is exemplified by an accumulation of protein aggregates in the brain in e.g. Alzheimer's and Parkinson's disease. In addition, in Alzheimer's disease there is an accumulation of autophagic vesicles within neuri...

ORGANISM(S): Homo sapiens (Human)

2019-09-25 | PXD012851 | Pride

Human Spe Csf Lc-ms/ms

Endo-Lysosomal Proteins and Ubiquitin CSF Concentrations in Alzheimer’s and Parkinson’s Disease

Alzheimer’s (AD) and Parkinson’s disease (PD) are neurodegenerative disorders characterized by an accumulation of protein aggregates in the brain. AD is the most common cause of dementia and presents with impairment of memory and cognition. PD results from the loss of dopaminergic neurons which resu...

ORGANISM(S): Homo Sapiens

2019-10-27 | PXD013451 | panorama

Vasopressor use after noncardiac surgery: an international observational study.

Not available

S-EPMC12799376 | biostudies-literature

Previous page
1 / 1
You're on page 1
Next page